These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 39058763)
1. Timing and location dictate monocyte fate and their transition to tumor-associated macrophages. Dunsmore G; Guo W; Li Z; Bejarano DA; Pai R; Yang K; Kwok I; Tan L; Ng M; De La Calle Fabregat C; Yatim A; Bougouin A; Mulder K; Thomas J; Villar J; Bied M; Kloeckner B; Dutertre CA; Gessain G; Chakarov S; Liu Z; Scoazec JY; Lennon-Dumenil AM; Marichal T; Sautès-Fridman C; Fridman WH; Sharma A; Su B; Schlitzer A; Ng LG; Blériot C; Ginhoux F Sci Immunol; 2024 Jul; 9(97):eadk3981. PubMed ID: 39058763 [TBL] [Abstract][Full Text] [Related]
2. Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition. Xiong C; Zhu Y; Xue M; Jiang Y; Zhong Y; Jiang L; Shi M; Chen H Aging (Albany NY); 2021 Jan; 13(3):3386-3404. PubMed ID: 33428605 [TBL] [Abstract][Full Text] [Related]
3. Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8. Chen SJ; Lian GD; Li JJ; Zhang QB; Zeng LJ; Yang KG; Huang CM; Li YQ; Chen YT; Huang KH Cancer Med; 2018 Nov; 7(11):5679-5690. PubMed ID: 30311406 [TBL] [Abstract][Full Text] [Related]
4. Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression. Hussain SM; Kansal RG; Alvarez MA; Hollingsworth TJ; Elahi A; Miranda-Carboni G; Hendrick LE; Pingili AK; Albritton LM; Dickson PV; Deneve JL; Yakoub D; Hayes DN; Kurosu M; Shibata D; Makowski L; Glazer ES Cell Oncol (Dordr); 2021 Jun; 44(3):673-687. PubMed ID: 33694102 [TBL] [Abstract][Full Text] [Related]
5. Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma. Tomasich E; Mühlbacher J; Wöran K; Hatziioannou T; Herac M; Kleinberger M; Berger JM; Dibon LK; Berchtold L; Heller G; Bergen ES; Macher-Beer A; Prager G; Schindl M; Preusser M; Berghoff AS Transl Res; 2024 Sep; 271():40-51. PubMed ID: 38734064 [TBL] [Abstract][Full Text] [Related]
7. Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal adenocarcinoma. Huang X; He C; Lin G; Lu L; Xing K; Hua X; Sun S; Mao Y; Song Y; Wang J; Li S Biochem Biophys Res Commun; 2020 Apr; 524(4):1064-1071. PubMed ID: 32070494 [TBL] [Abstract][Full Text] [Related]
8. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma. Zhang J; Sun H; Liu S; Huang W; Gu J; Zhao Z; Qin H; Luo L; Yang J; Fang Y; Ge J; Ni B; Wang H Aging (Albany NY); 2020 Nov; 12(22):23217-23232. PubMed ID: 33221741 [TBL] [Abstract][Full Text] [Related]
9. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy. Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960 [TBL] [Abstract][Full Text] [Related]
10. Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC. Bidan N; Dunsmore G; Ugrinic M; Bied M; Moreira M; Deloménie C; Ginhoux F; Blériot C; de la Fuente M; Mura S Drug Deliv Transl Res; 2024 Aug; 14(8):2085-2099. PubMed ID: 38062286 [TBL] [Abstract][Full Text] [Related]
11. Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages. Chen Q; Wang J; Zhang Q; Zhang J; Lou Y; Yang J; Chen Y; Wei T; Zhang J; Fu Q; Ye M; Zhang X; Dang X; Liang T; Bai X Br J Cancer; 2019 Oct; 121(9):786-795. PubMed ID: 31588122 [TBL] [Abstract][Full Text] [Related]
12. Differential Effects of Depleting versus Programming Tumor-Associated Macrophages on Engineered T Cells in Pancreatic Ductal Adenocarcinoma. Stromnes IM; Burrack AL; Hulbert A; Bonson P; Black C; Brockenbrough JS; Raynor JF; Spartz EJ; Pierce RH; Greenberg PD; Hingorani SR Cancer Immunol Res; 2019 Jun; 7(6):977-989. PubMed ID: 31028033 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impact. Komura T; Sakai Y; Harada K; Kawaguchi K; Takabatake H; Kitagawa H; Wada T; Honda M; Ohta T; Nakanuma Y; Kaneko S Cancer Sci; 2015 Jun; 106(6):672-686. PubMed ID: 25827621 [TBL] [Abstract][Full Text] [Related]
14. IL-1β Caronni N; La Terza F; Vittoria FM; Barbiera G; Mezzanzanica L; Cuzzola V; Barresi S; Pellegatta M; Canevazzi P; Dunsmore G; Leonardi C; Montaldo E; Lusito E; Dugnani E; Citro A; Ng MSF; Schiavo Lena M; Drago D; Andolfo A; Brugiapaglia S; Scagliotti A; Mortellaro A; Corbo V; Liu Z; Mondino A; Dellabona P; Piemonti L; Taveggia C; Doglioni C; Cappello P; Novelli F; Iannacone M; Ng LG; Ginhoux F; Crippa S; Falconi M; Bonini C; Naldini L; Genua M; Ostuni R Nature; 2023 Nov; 623(7986):415-422. PubMed ID: 37914939 [TBL] [Abstract][Full Text] [Related]
15. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice. Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066 [TBL] [Abstract][Full Text] [Related]
16. CD90 highly expressed population harbors a stemness signature and creates an immunosuppressive niche in pancreatic cancer. Shi J; Lu P; Shen W; He R; Yang MW; Fang Y; Sun YW; Niu N; Xue J Cancer Lett; 2019 Jul; 453():158-169. PubMed ID: 30954649 [TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages. Kemp SB; Steele NG; Carpenter ES; Donahue KL; Bushnell GG; Morris AH; The S; Orbach SM; Sirihorachai VR; Nwosu ZC; Espinoza C; Lima F; Brown K; Girgis AA; Gunchick V; Zhang Y; Lyssiotis CA; Frankel TL; Bednar F; Rao A; Sahai V; Shea LD; Crawford HC; Pasca di Magliano M Life Sci Alliance; 2021 Jun; 4(6):. PubMed ID: 33782087 [TBL] [Abstract][Full Text] [Related]
19. IFNα-induced BST2 Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878 [TBL] [Abstract][Full Text] [Related]
20. Distinct Stromal and Immune Features Collectively Contribute to Long-Term Survival in Pancreatic Cancer. Sadozai H; Acharjee A; Eppenberger-Castori S; Gloor B; Gruber T; Schenk M; Karamitopoulou E Front Immunol; 2021; 12():643529. PubMed ID: 33679807 [No Abstract] [Full Text] [Related] [Next] [New Search]